Nanomedicine Market

Nanomedicine Market (Application - Neurology, Cardiovascular, Anti-inflammatory, Anti-infective, and Oncology) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019

  • Rep Id : TMRGL1753
  • Published On : Jan 2014
  • No. of Pages : 81
  • Category : Pharmaceutical

 
Chapter 1 Preface
1.1 Report description
1.2 Research Methodology
1.3 Market Segmentation
 
Chapter 2 Executive Summary
 
Chapter 3 Global Nanomedicine Market Overview
3.1 Market Dynamics
      3.1.1 Market Drivers
               3.1.1.1 Improvement in technology for nanomedicine
               3.1.1.2 Rising government support for research and development in nanomedicine
               3.1.1.3 Presence of high unmet medical needs
               3.1.1.4 Increase in investment amount and healthcare collaborations
               3.1.1.5 High prevalence of chronic diseases
               3.1.1.6 Impact Analysis of the Market Drivers
      3.1.2 Market Restraints
               3.1.2.1 Lack of organized regulatory framework
               3.1.2.2 High costs involved
               3.1.2.3 Impact Analysis of the Market Restraints
      3.1.3 Market Opportunities
               3.1.3.1 Presence of unmet medical needs in emerging economies
               3.1.3.2 Identification of new medical applications
3.2 Porter’s Five Forces Analysis: Global Nanomedicine Market
      3.2.1 Bargaining Power of Suppliers
      3.2.2 Bargaining Power of Buyers
      3.2.3 Threat of New entrants
      3.2.4 Threat of Substitutes
      3.2.5 Competitive Rivalry
3.3 Market Attractiveness Analysis of the Global Nanomedicine Market, by Application
3.4 Global Nanomedicine Market, 2011 – 2019 (USD Million)
 
Chapter 4 Global Nanomedicine Market, by Applications
4.1 Overview
4.2 Nanomedicine for Neurology
      4.2.1 Global Nanomedicine for Neurology Market, 2011 – 2019 (USD Billion)
4.3 Nanomedicine for Cardiovascular (CVS)
      4.3.1 Global Nanomedicine for Cardiovascular Market , 2011 – 2019 (USD Billion)
4.4 Nanomedicine for Oncology
      4.4.1 Global Nanomedicine for Oncology Market , 2011 – 2019 (USD Billion)
4.5 Nanomedicine for Anti-inflammatory
      4.5.1 Global Nanomedicine for Anti-Inflammatory Market, 2011 – 2019 (USD Billion)
4.6 Nanomedicine for Anti-infectives
      4.6.1 Global Nanomedicine for Anti-Infectives Market, 2011 – 2019 (USD Billion)
4.7 Other Applications
      4.7.1 Global Nanomedicine Market for Other Applications, 2011 – 2019 (USD Billion)
4.8 Comparative Analysis: Global Nanomedicine Market by Applications, 2012 & 2019 (%)
 
Chapter 5 Global Nanomedicine Market, by Geography
5.1 Overview
      5.1.1 Comparative Analysis of the Global Nanomedicine Market, by Geography, 2012 & 2019 (%)
5.2 North America
      5.2.1 North America Nanomedicine Market, 2011 - 2019 (USD Billion)
5.3 Europe
      5.3.1 Europe Nanomedicine Market, 2011 - 2019 (USD Billion)
5.4 Asia-Pacific
      5.4.1 Asia-Pacific Nanomedicine Market, 2011 - 2019 (USD Billion)
5.5 Rest of the World
      5.5.1 Rest of the World Nanomedicine Market, 2011 - 2019 (USD Billion)
 
Chapter 6 Recommendations
6.1 Collaborating with educational institutions to boost interdisciplinary education and training
6.2 Identifying and prioritizing key growth areas
 
Chapter 7 Company Profiles
7.1 Abbott Laboratories
      7.1.1 Company Overview
      7.1.2 Financial Overview
      7.1.3 Product Portfolio
      7.1.4 Business Strategies
      7.1.5 Recent Developments
7.2 CombiMatrix Corporation
      7.2.1 Company Overview
      7.2.2 Financial Overview
      7.2.3 Product Portfolio
      7.2.4 Business Strategy
      7.2.5 Recent Developments
7.3 Celgene Corporation
      7.3.1 Company Overview
      7.3.2 Financial Overview
      7.3.3 Product Portfolio
      7.3.4 Business Strategies
      7.3.5 Recent Developments
7.4 Mallinckrodt plc.
      7.4.1 Company Overview
      7.4.2 Financial Overview
      7.4.3 Product Portfolio
      7.4.4 Business Strategies
      7.4.5 Recent Developments
7.5 GE Healthcare
      7.5.1 Company Overview
      7.5.2 Financial Overview
      7.5.3 Product Portfolio
      7.5.4 Business Strategies
      7.5.5 Recent Developments
7.6 Johnson & Johnson
      7.6.1 Company Overview
      7.6.2 Financial Overview
      7.6.3 Product Portfolio
      7.6.4 Business Strategies
      7.6.5 Recent Developments
7.7 Merck & Company Inc.
      7.7.1 Company Overview
      7.7.2 Financial Overview
      7.7.3 Product Portfolio
      7.7.4 Business Strategies
      7.7.5 Recent Developments
7.8 Nanosphere, Inc.
      7.8.1 Company Overview
      7.8.2 Financial Overview
      7.8.3 Product Portfolio
      7.8.4 Business Strategies
      7.8.5 Recent Developments
7.9 Pfizer Inc.
      7.9.1 Company Overview
      7.9.2 Financial Overview
      7.9.3 Product Portfolio
      7.9.4 Business Strategies
7.10 Sigma-Tau Pharmaceuticals Inc.
      7.10.1 Company Overview
      7.10.2 Financial Overview
      7.10.3 Product Portfolio
      7.10.4 Business Strategies
      7.10.5 Recent Developments
7.11 Teva Pharmaceutical Industries Ltd.
      7.11.1 Company Overview
      7.11.2 Financial Overview
      7.11.3 Product Portfolio
      7.11.4 Business Strategy
      7.11.5 Recent Developments
7.12 UCB SA
      7.12.1 Company Overview
      7.12.2 Financial Overview
      7.12.3 Product Portfolio
      7.12.4 Business Strategies
      7.12.5 Recent Developments

List of Tables
 
TABLE 1 Market Snapshot: Global Nanomedicine Market
TABLE 2 Impact Analysis of the Market Drivers for the Global Nanomedicine Market
TABLE 3 Impact Analysis of the Market Restraints for the Global Nanomedicine Market
TABLE 1 Global Nanomedicine Market, by Applications, 2011 -2019 (USD Billion)
TABLE 2 Global Nanomedicine Market, by Geography, 2011 - 2019 (USD Billion)

List of Figures
 
FIG. 1 Market Segmentation for the Nanomedicine Market
FIG. 2 Global Nanomedicine Market, by Application and Geography, 2012 (USD Billion)
FIG. 3 Porter’s Five Forces Analysis: Global Nanomedicine Market
FIG. 4 Market Attractiveness Analysis of the Global Nanomedicine Market, by Application
FIG. 5 Global Nanomedicine Market, 2011 – 2019 (USD Billion)
FIG. 6 Global Nanomedicine for Neurology Market, 2011 - 2019 (USD Billion)
FIG. 7 Global Nanomedicine for Cardiovascular Market, 2011 - 2019 (USD Billion)
FIG. 8 Global Nanomedicine for Oncology Market, 2011 - 2019 (USD Billion)
FIG. 9 Global Nanomedicine for Anti-Inflammatory Market, 2011 - 2019 (USD Billion)
FIG. 10 Global Nanomedicine for Anti-Infective Market, 2011 - 2019 (USD Billion)
FIG. 11 Global Nanomedicine Market  for Other Applications, 2011 - 2019 (USD Billion)
FIG. 12 Comparative Analysis: Global Nanomedicine Market by Applications, 2012 & 2019 (Value %)
FIG. 13 Comparative Analysis of the Global Nanomedicine Market, by Geography, 2012 & 2019 (%)
FIG. 14 North America Nanomedicine Market, 2011 - 2019 (USD Billion)
FIG. 15 Europe Nanomedicine Market, 2011 - 2019 (USD Billion)
FIG. 16 Asia-Pacific Nanomedicine Market, 2011 - 2019 (USD Billion)
FIG. 17 Rest of the World Nanomedicine Market, 2011 - 2019 (USD Billion)
FIG. 18 Abbott Laboratories: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 19 CombiMatrix Corporation: Annual Sales, 2010 – 2012 (USD Million)
FIG. 20 Celgene Corporation: Annual Sales, 2010 – 2012 (USD Million)
FIG. 21 Covidien Plc.: – Annual Revenue, 2010 – 2012 (USD Million)
FIG. 22 GE Healthcare: Annual Revenue, 2010–2012 (USD Million)
FIG. 23 Johnson & Johnson: Medical Devices and Diagnostic Business Segment, Annual Revenue, 2010 – 2012 (USD Million)
FIG. 24 Merck & Co. Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 25 Nanosphere Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 26 Pfizer Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 27 Teva Pharmaceutical Industries Ltd.: Annual Revenue, 2010–2012 (USD Million)
FIG. 28 UCB S.A.: Annual Revenue, 2010 – 2012 (USD Million)

.